Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, TDS

A New Level of Engagement in CPR Training - Laerdal Medical Introduces Little Anne® QCPR


WAPPINGERS FALLS, N.Y., Oct. 18, 2017 /PRNewswire/ -- Achieving student engagement is a fundamental challenge in any form of education ? including Cardiopulmonary Resuscitation (CPR) training. To help improve the classroom experience and learner outcomes, Laerdal Medical has launched the next generation of Little Anne®, which includes Quality-CPR (QCPR) functionality. Today, Laerdal Medical debuted the new manikin at EMS World Expo in Las Vegas, NV.

Learners perform compressions on Little Anne® QCPR while the CPR instructor provides feedback via the Instructor App.

Little Anne® QCPR includes objective feedback and measurement technology to take the guesswork out of instruction. Using Bluetooth Smart technology, Little Anne® QCPR can connect with a feedback application downloaded to a smartphone or tablet. The manikin can be used with an Instructor App, which provides a performance overview and monitoring of up to six manikins at once, and a Learner App, which allows students to monitor their own individual performance. Both apps are free downloads. Little Anne® QCPR can also provide feedback via a tethered SkillGuide device.

This newly-enhanced manikin helps increase training efficiency and effectiveness, while the feedback and scoring help to increase learner engagement and confidence. Key features include:

Existing Little Anne manikins can be upgraded to QCPR using the Little Anne QCPR Upgrade Kit, which is a quick and simple upgrade that can be performed by the customer.

"Laerdal has been committed to developing high-quality CPR training solutions since Resusci Anne was introduced in 1960.  Now, Little Anne QCPR builds on that legacy and brings exciting new "technology-based feedback" to support both CPR Instructors and lay students involved with bystander CPR training," says David Johnson, President, Laerdal Medical, Americas.

To learn more about Little Anne® QCPR, visit www.Laerdal.com/LittleAnneQCPR.

About Laerdal

Laerdal Medical is dedicated to the mission of helping save lives through the advancement of simulation-based training in the fields of resuscitation, patient care, and emergency care training. Laerdal products and programs are used by educational institutions, hospitals, Emergency Medical Services (EMS), and military around the world. For more information, visit www.laerdal.com.

Press Contact

Danica McDonough, Media Relations
Email: [email protected] 
Telephone: (845) 297-7770

 (PRNewsfoto/Laerdal Medical)

SOURCE Laerdal Medical


These press releases may also interest you

at 06:10
Confo Therapeutics, a leader in the discovery of novel medicines targeting G-protein coupled receptors (GPCRs), announced today that it has been awarded a EUR 1.6 million grant from Flanders Innovation & Entrepreneurship (VLAIO). The 2-year grant...

at 06:08
Aesthetic Management Partners LLC, a manufacturer of skin-based solutions and a provider of energy-based devices announces its collaboration with Croma (Croma-Pharma® GmbH), a global player in the minimally invasive aesthetics market and a leading...

at 06:05
The 2023 U.S. soybean field trials conducted by Texas Crop Science (TCS) demonstrated an average yield increase of 21% in soybean lines incorporating the TCS yield trait. This breakthrough in performance would generate approximately $121 per acre in...

at 06:05
3EO Health, a "Point of Life" diagnostics company focused on the development of high-performing low-cost molecular diagnostics, is excited to announce the next step in their quest to make molecular testing affordable. Today, the company has published...

at 06:05
Zura Bio Limited ("Zura Bio") a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today reported full year 2023 financial results and recent business highlights. The Company has also...

at 06:00
Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced the appointment of Dr. Neil Gallagher to...



News published on and distributed by: